Journal of Cutaneous and Aesthetic Surgery

REVIEW ARTICLES
Year
: 2021  |  Volume : 14  |  Issue : 3  |  Page : 285--294

Intralesional agents in dermatology: Pros and cons


Jagdish Sakhiya1, Dhruv Sakhiya2, Jitesh Kaklotar1, Bansi Hirapara1, Madhav Purohit1, Krishna Bhalala1, Feral Daruwala1, Nimish Dudhatra1 
1 Sakhiya Skin Clinic, 2nd Floor, Ayush Doctor House, Station-Lal Darwaja Road, Surat, Gujarat, India
2 B.J. Medical College, New Civil Hospital Asarwa, Ahmedabad, Gujarat, India

Correspondence Address:
Dr. Jagdish Sakhiya
Sakhiya Skin Clinic, 2nd Floor, Ayush Doctor House, Station-Lal Darwaja Road, Surat 395003, Gujarat.
India

Since introduced in 1961, intralesional (IL) agent has become an essential part of the dermatological practice. The term IL referred to the direct delivery of agent percutaneously into skin lesions. This therapeutic approach is relatively safe, easy to perform and applicable for a broad range of dermatological conditions. On the other hand, immediate side effects, including pain during administration, bleeding, high risk of infection and allergic reaction, and subsequent side effects involving skin changes such as atrophy, telangiectasia, pigmentary changes, and striae are usually associated with this modality. This review paper highlights the pros and cons of IL agents in modern dermatology practice.


How to cite this article:
Sakhiya J, Sakhiya D, Kaklotar J, Hirapara B, Purohit M, Bhalala K, Daruwala F, Dudhatra N. Intralesional agents in dermatology: Pros and cons.J Cutan Aesthet Surg 2021;14:285-294


How to cite this URL:
Sakhiya J, Sakhiya D, Kaklotar J, Hirapara B, Purohit M, Bhalala K, Daruwala F, Dudhatra N. Intralesional agents in dermatology: Pros and cons. J Cutan Aesthet Surg [serial online] 2021 [cited 2021 Dec 5 ];14:285-294
Available from: https://www.jcasonline.com/article.asp?issn=0974-2077;year=2021;volume=14;issue=3;spage=285;epage=294;aulast=Sakhiya;type=0